Aromatase inhibitors

E126 Pill - yellow round, 6mm

Pill with imprint E126 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Qualitest Pharmaceuticals.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-E126-2.5 mg-Yellow-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: E126
Strength: 2.5 mg
Color: Yellow
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00603-4180 (Discontinued)
Inactive Ingredients: Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol, Polyvinyl alcohol, Corn starch, Magnesium silicate, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs